Titan Pharma (TTNP)

$5.18 +0.25 (5.07%)
Market Cap 4.51M
Revenue (ttm) 0.00
Net Income (ttm) -4.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 8,565
Avg Vol 31,020
Day's Range N/A - N/A
Shares Out 914,000.00
Stochastic %K 83%
Beta 1.29
Analysts Strong Buy
Price Target $7.00

Company Profile

Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.

Industry: Biotechnology
Sector: Healthcare
Phone: 650 244 4990
Address:
10 East 53rd St., Suite 3001, New York, United States
d_risk
d_risk Aug. 16 at 11:05 PM
$TTNP - TITAN PHARMACEUTICALS INC - 10Q - Updated Risk Factors TTNP’s updated risks note regained Nasdaq compliance after equity-boosting private placements and annual meeting fixes, but ongoing monitoring and potential delisting threats persist. #Pharmaceuticals #NasdaqListing #MarketRisk #RegulatoryCompliance #EquityFinancing 🟢 Added 🟠 Removed https://d-risk.ai/TTNP/10-Q/2025-08-14
0 · Reply
BioTerror
BioTerror Aug. 13 at 6:27 PM
$TTNP watching 5.20 break!
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 12 at 5:28 PM
$TTNP Titan Pharmaceuticals’ innovative therapy delivery system is disrupting the status quo. Here’s why it could be the next biotech star! https://biotechhealthx.com/biotech-news/titan-pharma-ttnp-this-tiny-drugmaker-is-taking-on-big-pharma-and-could-win/
0 · Reply
BioTerror
BioTerror Aug. 12 at 4:30 PM
$TTNP if this breaks past 5.20 it's going to $12!
0 · Reply
BioTerror
BioTerror Aug. 5 at 3:03 PM
$CWD called this. Now loading $TTNP
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 29 at 7:52 PM
$ATNF -6%[8%] $TTNP 6%[-11%] $RCON 6%[-20%] $PTHL 6%[-95%] $AEHL 5%[-13%] most notable movement into the final minutes of trading.
0 · Reply
Lee_Iacocca
Lee_Iacocca Jul. 29 at 5:31 PM
$TTNP
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 29 at 4:57 PM
$TTNP just slipped -5% lower to -14% (~500Kv) moments ago, follow for more volatility.
0 · Reply
Anticommie
Anticommie Jul. 29 at 3:08 PM
$TTNP Love how it's says extremely bullish but just goes down. Hilarious!
0 · Reply
bazzi22222
bazzi22222 Jul. 29 at 12:50 PM
$TTNP Never understood this
1 · Reply
Latest News on TTNP
TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

Aug 5, 2025, 9:24 PM EDT - 12 days ago

TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP

Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock

Jun 27, 2025, 4:05 PM EDT - 7 weeks ago

Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock

Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.

Jun 3, 2025, 8:45 AM EDT - 2 months ago

Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock

Apr 11, 2025, 4:15 PM EDT - 4 months ago

Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock

Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq

Nov 27, 2024, 4:05 PM EST - 9 months ago

Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

Aug 19, 2024, 4:11 PM EDT - 1 year ago

Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

Jan 25, 2024, 4:29 PM EST - 1 year ago

Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio

Dec 28, 2023, 4:15 PM EST - 1 year ago

Titan Pharmaceuticals Announces Reverse Stock Split and Ratio

Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors

Oct 16, 2023, 4:37 PM EDT - 1 year ago

Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors

Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock

Sep 18, 2023, 7:30 AM EDT - 2 years ago

Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock

Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets

Jul 27, 2023, 7:30 AM EDT - 2 years ago

Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets

Titan Pharmaceuticals Provides Shareholder Update

Dec 15, 2022, 7:00 AM EST - 2 years ago

Titan Pharmaceuticals Provides Shareholder Update

UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.

Dec 12, 2022, 7:49 AM EST - 2 years ago

UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc.

Titan Pharmaceuticals Announces Board Expansion and Management Changes

Aug 16, 2022, 10:53 AM EDT - 3 years ago

Titan Pharmaceuticals Announces Board Expansion and Management Changes

Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

Jul 5, 2022, 8:00 AM EDT - 3 years ago

Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

Jun 10, 2022, 8:00 AM EDT - 3 years ago

Activist Investing Discloses 9.9% Ownership Interest in Titan Pharmaceuticals, Inc.

Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.

Apr 25, 2022, 1:29 PM EDT - 3 years ago

Activist Investing Announces 5.6% Ownership Interest in Titan Pharmaceuticals, Inc.

Titan Pharmaceuticals Raises $5.5M Via Equity

Feb 2, 2022, 12:27 PM EST - 3 years ago

Titan Pharmaceuticals Raises $5.5M Via Equity

Titan Pharmaceuticals Announces Pricing of $5.5 Million Registered Direct and PIPE Offering Priced At-The-Market

Feb 2, 2022, 8:45 AM EST - 3 years ago

Titan Pharmaceuticals Announces Pricing of $5.5 Million Registered Direct and PIPE Offering Priced At-The-Market

Titan Pharmaceuticals to Explore Strategic Alternatives

Dec 21, 2021, 8:00 AM EST - 3 years ago

Titan Pharmaceuticals to Explore Strategic Alternatives

Sustained Anti-Pruritic Effect Of Titan's TP-2021 Implant Reported Today At Neuroscience 2021

Nov 8, 2021, 4:15 PM EST - 4 years ago

Sustained Anti-Pruritic Effect Of Titan's TP-2021 Implant Reported Today At Neuroscience 2021

Titan Announces Upcoming TP-2021 Implant Data Presentation at Neuroscience 2021

Nov 5, 2021, 4:30 PM EDT - 4 years ago

Titan Announces Upcoming TP-2021 Implant Data Presentation at Neuroscience 2021

Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries

Oct 25, 2021, 7:15 AM EDT - 4 years ago

Titan Pharmaceuticals Receives Funding to Develop Combination HIV Therapeutic and Contraceptive Implant for Women in Developing Countries

Titan Pharmaceuticals and MUSC FRD Enter Into Research and Option License Agreement

Oct 12, 2021, 8:00 AM EDT - 4 years ago

Titan Pharmaceuticals and MUSC FRD Enter Into Research and Option License Agreement

Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus

Jun 23, 2021, 8:00 AM EDT - 4 years ago

Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus

Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K

Mar 31, 2021, 4:30 PM EDT - 4 years ago

Titan Pharmaceuticals Announces Filing Of 2020 Annual Report On Form 10-K

Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development Program

Feb 1, 2021, 7:30 AM EST - 4 years ago

Positive Early Study Results Help Pave Wave for Titan Pharmaceuticals to Move Forward with its JT-09 ProNeura® Development Program

Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct Offering

Jan 15, 2021, 9:15 AM EST - 4 years ago

Titan Pharmaceuticals Announces Pricing of $9.7 Million Registered Direct Offering

Titan Pharmaceuticals Announces Reverse Stock Split

Nov 30, 2020, 12:50 PM EST - 5 years ago

Titan Pharmaceuticals Announces Reverse Stock Split

Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results

Nov 16, 2020, 8:45 AM EST - 5 years ago

Titan Pharmaceuticals Reports Third Quarter 2020 Financial Results

Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering

Oct 28, 2020, 3:00 PM EDT - 5 years ago

Titan Pharmaceuticals Announces Pricing of $8.0 Million Underwritten Public Offering

Titan Pharmaceuticals Announces Debt Settlement Agreement with Molteni and Horizon

Oct 26, 2020, 6:30 AM EDT - 5 years ago

Titan Pharmaceuticals Announces Debt Settlement Agreement with Molteni and Horizon

Titan Pharmaceuticals' Stockholders Approve Proposal To Amend Its Certificate Of Incorporation

Sep 18, 2020, 4:45 PM EDT - 5 years ago

Titan Pharmaceuticals' Stockholders Approve Proposal To Amend Its Certificate Of Incorporation

Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its Certificate Of Incorporation

Sep 14, 2020, 8:30 AM EDT - 5 years ago

Titan Pharmaceuticals Provides Update To Stockholders On Proposal To Amend Its Certificate Of Incorporation

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2020 Results - Earnings Call Transcript

Aug 14, 2020, 7:08 PM EDT - 5 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2020 Results - Earnings Call Transcript

Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results

Aug 14, 2020, 8:45 AM EDT - 5 years ago

Titan Pharmaceuticals Reports Second Quarter 2020 Financial Results

Titan Pharmaceuticals To Report Second Quarter 2020 Financial Results On August 14, 2020

Aug 10, 2020, 4:30 PM EDT - 5 years ago

Titan Pharmaceuticals To Report Second Quarter 2020 Financial Results On August 14, 2020

Titan Pharmaceuticals Urges Stockholders to Vote "FOR" Proposal to Amend Its Certificate of Incorporation

Jul 8, 2020, 8:00 AM EDT - 5 years ago

Titan Pharmaceuticals Urges Stockholders to Vote "FOR" Proposal to Amend Its Certificate of Incorporation

Titan Pharmaceuticals And Indegene Enter Into Probuphine® Co-Promotion Partnership

Jun 24, 2020, 8:00 AM EDT - 5 years ago

Titan Pharmaceuticals And Indegene Enter Into Probuphine® Co-Promotion Partnership

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2020 Results - Earnings Call Transcript

May 15, 2020, 8:30 PM EDT - 5 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2020 Results - Earnings Call Transcript

Titan Pharmaceuticals Reports First Quarter 2020 Financial Results

May 15, 2020, 8:45 AM EDT - 5 years ago

Titan Pharmaceuticals Reports First Quarter 2020 Financial Results

Penny Stocks to Buy Using Technical Analysis for April 2020

Mar 31, 2020, 12:43 PM EDT - 5 years ago

Penny Stocks to Buy Using Technical Analysis for April 2020

CPIX OSG

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2019 Results - Earnings Call Transcript

Mar 30, 2020, 7:43 PM EDT - 5 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2019 Results - Earnings Call Transcript

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q3 2019 Results - Earnings Call Transcript

Nov 14, 2019, 10:16 PM EST - 6 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q3 2019 Results - Earnings Call Transcript

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2019 Results - Earnings Call Transcript

Aug 14, 2019, 10:19 PM EDT - 6 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q2 2019 Results - Earnings Call Transcript

Q2 Earnings Preview For Titan Pharmaceuticals

Aug 14, 2019, 7:32 AM EDT - 6 years ago

Q2 Earnings Preview For Titan Pharmaceuticals

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2019 Results - Earnings Call Transcript

May 15, 2019, 9:56 PM EDT - 6 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q1 2019 Results - Earnings Call Transcript

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2018 Results - Earnings Call Transcript

Apr 2, 2019, 12:50 PM EDT - 6 years ago

Titan Pharmaceuticals, Inc. (TTNP) CEO Sunil Bhonsle on Q4 2018 Results - Earnings Call Transcript

d_risk
d_risk Aug. 16 at 11:05 PM
$TTNP - TITAN PHARMACEUTICALS INC - 10Q - Updated Risk Factors TTNP’s updated risks note regained Nasdaq compliance after equity-boosting private placements and annual meeting fixes, but ongoing monitoring and potential delisting threats persist. #Pharmaceuticals #NasdaqListing #MarketRisk #RegulatoryCompliance #EquityFinancing 🟢 Added 🟠 Removed https://d-risk.ai/TTNP/10-Q/2025-08-14
0 · Reply
BioTerror
BioTerror Aug. 13 at 6:27 PM
$TTNP watching 5.20 break!
0 · Reply
BioTechHealthX
BioTechHealthX Aug. 12 at 5:28 PM
$TTNP Titan Pharmaceuticals’ innovative therapy delivery system is disrupting the status quo. Here’s why it could be the next biotech star! https://biotechhealthx.com/biotech-news/titan-pharma-ttnp-this-tiny-drugmaker-is-taking-on-big-pharma-and-could-win/
0 · Reply
BioTerror
BioTerror Aug. 12 at 4:30 PM
$TTNP if this breaks past 5.20 it's going to $12!
0 · Reply
BioTerror
BioTerror Aug. 5 at 3:03 PM
$CWD called this. Now loading $TTNP
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 29 at 7:52 PM
$ATNF -6%[8%] $TTNP 6%[-11%] $RCON 6%[-20%] $PTHL 6%[-95%] $AEHL 5%[-13%] most notable movement into the final minutes of trading.
0 · Reply
Lee_Iacocca
Lee_Iacocca Jul. 29 at 5:31 PM
$TTNP
0 · Reply
_www_larval_com_
_www_larval_com_ Jul. 29 at 4:57 PM
$TTNP just slipped -5% lower to -14% (~500Kv) moments ago, follow for more volatility.
0 · Reply
Anticommie
Anticommie Jul. 29 at 3:08 PM
$TTNP Love how it's says extremely bullish but just goes down. Hilarious!
0 · Reply
bazzi22222
bazzi22222 Jul. 29 at 12:50 PM
$TTNP Never understood this
1 · Reply
uratwitx2
uratwitx2 Jul. 29 at 11:46 AM
$TTNP Sure seems like the float is locked - what will the MM do now? Has to BUY BUY BUY! LFG!
0 · Reply
uratwitx2
uratwitx2 Jul. 29 at 11:40 AM
$TTNP holding 4k shares.....
0 · Reply
Rasto2020
Rasto2020 Jul. 27 at 11:05 PM
$TTNP that drop on no volume,.. I’ll be definitely watching
0 · Reply
KingOblivious
KingOblivious Jul. 25 at 3:04 PM
$TTNP Things getting real here. Can't buy securities. Shady 💩
0 · Reply
ChartChartist
ChartChartist Jul. 25 at 1:53 PM
$TTNP was not expecting that turding
0 · Reply
ICEMAN_ALERTS
ICEMAN_ALERTS Jul. 24 at 11:49 PM
$TTNP on the uptrend now
0 · Reply
Doozio
Doozio Jul. 24 at 7:06 PM
$TTNP it can’t be a Thursday 🐑 if all them bums been SPOT. Where are all the other 33k followers during 🐒🍌🧠⏰♾️?
0 · Reply
ChartChartist
ChartChartist Jul. 24 at 5:35 PM
$TTNP been
0 · Reply
Doozio
Doozio Jul. 24 at 10:43 AM
$NEUP meet $TTNP then scrabble bag it with $TNXP and it becomes obviously as $XBI gets in RYTM with the list of 🧠 $STOK s its about to spread TTWO as it becomes LGNDary during 🐒🍌🧠⏰♾️
2 · Reply
Doozio
Doozio Jul. 24 at 9:59 AM
$TTNP 🐒🍌🧠⏰♾️
0 · Reply
Solvanic
Solvanic Jul. 23 at 5:21 PM
$TTNP ⁨WKSP showing steady accumulation, multiple 100-share buys in quick succession👀 Volume is flowing✅ Watching for a move through $4.00 🚀⁩
0 · Reply
Doozio
Doozio Jul. 23 at 5:02 PM
$TTNP let it spread 🐒🍌🧠⏰♾️
0 · Reply